Skip to navigation bar Skip to breadcrumbs Skip to page content
clear place holder Browse All Topics Envelope icon E-mail Updates Teal square Text size:  a A A

Rh(D) Incompatibility: Screening

Release Date: February 2004

Recommendation Summary

Summary of Recommendations

PopulationRecommendationGrade
(What's This?)
Pregnant women, during the first pregnancy-related care visit

The USPSTF strongly recommends Rh(D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care. 

The USPSTF recommends the service. There is high certainty that the net benefit is substantial.
Unsensitized Rh(D)-negative pregnant women

The USPSTF recommends repeated Rh(D) antibody testing for all unsensitized Rh(D)-negative women at 24 to 28 weeks' gestation, unless the biological father is known to be Rh(D)-negative. 

The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.

Related Information for Consumers

There is no related information for consumers.

Related Information for Health Professionals

There is no related information for health professionals.

Clinical Summary

Clinical summaries are one-page documents that provide guidance to primary care clinicians for using recommendations in practice.

There is no Clinical Summary for this recommendation.

 
Current as of: July 2015

Internet Citation: Final Update Summary: Rh(D) Incompatibility: Screening. U.S. Preventive Services Task Force. July 2015.
https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/rh-d-incompatibility-screening

USPSTF Program Office   5600 Fishers Lane, Mail Stop 06E53A, Rockville, MD 20857